awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53737270-0E11CFE3-ABCC-4955-96D8-AFD8A3924D8C
Q53737270-0E11CFE3-ABCC-4955-96D8-AFD8A3924D8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-0E11CFE3-ABCC-4955-96D8-AFD8A3924D8C
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.
P2860
Q53737270-0E11CFE3-ABCC-4955-96D8-AFD8A3924D8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-0E11CFE3-ABCC-4955-96D8-AFD8A3924D8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
788f29350194d53b61dfa73175e96d1067ac773a
P2860
Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.